Mega Genomics Limited (6667) Stock Statistics & Valuation Metrics

Mega Genomics Limited has a market cap or net worth of HK$1.61B. The enterprise value is HK$883.70M.

Mega Genomics Limited has 224,300,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mega Genomics Limited’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 5.03%.

The current PE Ratio of Mega Genomics Limited is 47.8. Mega Genomics Limited’s PEG ratio is 0.00.

In the last 12 months, Mega Genomics Limited had revenue of 247.15M and earned 26.32M in profits. Earnings per share was 0.13.

In the last 12 months, operating cash flow was -15.33M and capital expenditures -53.09K, giving a free cash flow of -15.39M billion.

Mega Genomics Limited pays an annual dividend of HK$0.17, resulting in a dividend yield of ―

Mega Genomics Limited upcoming earnings date is Aug 27, 2026, TBA (Confirmed).

Mega Genomics Limited as a current ratio of 3.64, with Debt / Equity ratio of 4.81%

In the past 12 months, Mega Genomics Limited has paid 5.81M in taxes.

Mega Genomics Limited EV to EBITDA ratio is 17.93, with an EV/FCF ratio of -53.40.

Mega Genomics Limited has HK$435.70M in cash and marketable securities with HK$29.37M in debt, giving a net cash position of HK$406.33M billion.

Gross margin is 47.49%, with operating margin of 15.83%, and net profit margin of 10.65%.

The average price target for Mega Genomics Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―